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Nuclear factor TDP-43 is an evolutionarily conserved multifunctional RNA-binding protein associated
with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). In recent years,
Drosophila models of ALS based on TDP-43 knockdown/overexpression have allowed to ﬁnd several
connections with disease. Among these, we have previously described that silencing the expression of its
ﬂy ortholog (TBPH) can alter the expression of the neuronal microtubule-associated protein Futsch
leading to alterations of neuromuscular junction (NMJ) organization. In particular, TBPH knocked out ﬂies
displayed a signiﬁcant reduction of Futsch protein levels, although minimal variation in the futsch mRNA
content was observed. These conclusions were recently validated in an independent study. Together,
these observations strongly support the hypothesis that TBPH might regulate the translation of futsch
mRNA. However, the mechanism of TBPH interference in futschmRNA translation is still unknown. In this
work, we use EMSA experiments coupled with RNA-protein co-immunprecipitations and luciferase as-
says to show that TBPH interacts with a stretch of UG within the 5′UTR of futschmRNA and translation is
positively modulated by this binding. Most importantly, this function is also conserved in human TDP-43.
This result can therefore represent the ﬁrst step in elucidating the relationship between TDP-43, protein
translation, and eventual disease onset or progression.
This article is part of a Special Issue entitled SI:RNA Metabolism in Disease.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Transactive response DNA binding protein 43 kDa (TDP-43) is a
multifunctional nuclear factor that regulates expression, splicing,
transport, and mRNA stability of numerous cellular genes, in-
cluding its own transcript (Ayala et al., 2011; Buratti and Baralle,
2012).
In human disease, TDP-43 aggregation and/or the presence of
mutations in the TAR DNA binding protein (TARDBP) gene have
been associated with the development of different neurodegen-
erative disorders, principally Amyotrophic Lateral Sclerosis (ALS)
and Frontotemporal Dementia (FTLD) (Arai et al., 2006; Buratti,
2015; Janssens and Van Broeckhoven, 2013; Kabashi et al., 2008;
Neumann et al., 2006; Polymenidou et al., 2011; Tollervey et al.,
2011).
Since this discovery, many animal models have been developed
that aim to reproduce at least some of the aspects of these diseases
by overexpressing either the wild type or mutated forms of thisr B.V. This is an open access articlprotein.
Importantly, all these studies have taken advantage of the fact
that TDP-43 structure and function is highly conserved through
evolution (Ayala et al., 2005). Accordingly, several animal models
show that both knockdown and overexpression of this factor re-
capitulate different aspects of ALS pathology such as neuronal
degeneration and locomotor alterations (Belzil et al., 2013; Lee
et al., 2012; Liu et al., 2013; Wegorzewska and Baloh, 2011).
In particular, several studies have used Drosophila as a model
system, because the ﬂy TDP-43 ortholog (TBPH) is structurally and
functionally homolog to the human nuclear factor (Ayala et al.,
2005; Buratti et al., 2004; Romano et al., 2014b). In general,
therefore, Drosophila TDP-43-related models suggest that TBPH
controls phenotypes that can be associated with human ALS pa-
thology (Romano et al., 2012).
For this reason, characterization of TBPH physiological and
pathological functions can provide important insights into ALS
pathophysiology. In particular, among the Drosophila genes whose
expression is regulated by TBPH, there are several genes known to
code for different pre-synaptic proteins. Speciﬁcally, in the pre-
synaptic compartment the expression levels of Futsch, Syntaxin 1Ae under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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become downregulated after neuronal suppression of TBPH. This
suggests that TBPH can inﬂuence synaptic transmission through
direct or indirect modulation of proteins controlling microtubule
network or synaptogenesis (Feiguin et al., 2009; Romano et al.,
2014a).
Among these factors, the futsch gene (CG34387; FBgn0259108)
was the ﬁrst gene identiﬁed as mis-regulated in TBPH-null ﬂies
(Feiguin et al., 2009). In addition to the fact that futsch is the ﬂy
homolog of human MAP1B, this gene was particularly interesting
because TBPH-null ﬂies showed a signiﬁcant reduction in futsch
protein expression without modiﬁcation of futsch mRNA levels.
However, co-immunopreciptation assays demonstrated that TBPH
protein can strongly interact with futsch mRNA (Feiguin et al.,
2009; Godena et al., 2011). These observations suggested a direct
role of TBPH in the post-transcriptional regulation of futsch ex-
pression. In this case, therefore, TBPH might be acting similarly to
what demonstrated for the Drosophila Fragile X-related protein,
another RNA binding protein, that works as a translational re-
pressor of futsch to ﬁnely tune synaptic growth (Zhang et al.,
2001). In addition to these data, a recent report has further sup-
ported a role of TBPH in futsch protein translation (Coyne et al.,
2014). Interestingly, this study conﬁrmed that TDP-43 interacts
in vivo with futsch mRNA and showed that this interaction mod-
ulates the intra-cellular transport/localization and translation of
this mRNA in ﬂy motor neurons (Coyne et al., 2014). This study
also suggested that TBPH might sequester futsch mRNA into RNPFig. 1. TDP-43 binds to UGs within the futsch 5′UTR region. (A) Sequence of the in vitro t
(boldfaced) were ampliﬁed by PCR (gray shaded sequence). The sequence of the forward
RNA transcription. (B) EMSA analysis with both recombinant GST-TDP-43 and GST–TBP
(C) TDP-43 binds speciﬁcally the UG-rich-tract within the 5′UTR futsch RNA. The interact
successfully competed with cold wild type futsch 5′UTR RNA (lanes 3 and 4), but not by c
futsch RNA by TDP-43. This experiment shows the RT-qPCR analysis of 5′UTR futsch RNA
unrelated protein (EGFP) or to the mutant TDP-43 F/L that is unable to bind RNA (TDP-4
ΔUG futsch 5′UTR RNA. This analysis conﬁrms the interaction of TDP-43 with the UG-ricomplexes and regulate its expression in motor neuron cell bodies
through its controlled release (Coyne et al., 2014). Notwithstand-
ing these concordant lines of evidence connecting TBPH/TDP-43
with the translation process, it is not yet clear whether this action
is direct or not. Therefore, the aim of this work was to better
characterize this process by mapping the yet unknown binding
site of TBPH/TDP-43 to the futsch mRNA and validating its func-
tional importance in the translation process.2. Results
2.1. Mapping in vitro the interaction of TBPH/TDP-43 with the 5′UTR
of futsch mRNA
Considering the importance of 5′UTRs sequences for transla-
tional regulation of gene expression (Araujo et al., 2012), it was
very likely that TBPH could play a role in the translation of the
futsch mRNA by binding to this particular region.
More speciﬁcally, we observed that futsch mRNA 5′UTR con-
tains a stretch of UGs (Fig. 1A). Considering that both TBPH and
TDP-43 share the ability to bind to UG-rich sequences with high
afﬁnity, we then tested whether TBPH/TDP-43 could bind this
region. To this end, we performed EMSA analysis (Electrophoretic
Mobility Shift Assay) using a labeled probe containing this se-
quence and puriﬁed recombinant TBPH/TDP-43. This experiment
clearly showed that both the ﬂy and human TDP-43 proteins canranscribed RNA. Both wild type and ΔUG futsch 5′-UTRs including the UG-rich tract
oligo (underlined) includes the T7 promoter used for either the cold or 32P-labeled
H proteins shows that the proteins can bind UG-rich RNAs at comparable levels.
ion of GST-TDP-43 with the 32P-labeled UG-sequence of futsch 5′UTR (lane 2) can be
old ΔUG futsch 5′UTR RNA (lanes 5 and 6). (C) Co-immunoprecipitation of the 5′UTR
immunoprecipitated by Flag-tagged TDP-43. The enrichment-fold is referred to an
3 F/L). Signiﬁcant levels of enrichment were observed for the wild type but not for
ch tract of futsch 5′UTR mRNA.
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abolished by the deletion of the UG-rich tract (Fig. 1B).
The binding speciﬁcity of TBPH for the 5′UTR of futsch was also
conﬁrmed by competition studies where increasing amounts of
unlabeled wild type or ΔUG 5′UTR futsch RNA were used to
compete with radioactive wild type 5′UTR futsch RNA for GST–
TBPH binding (Fig. 1C). As shown in this ﬁgure, increasing amounts
of wild type cold 5′UTR RNA were able to effectively interfere with
the interaction between TBPH and the labeled probe. However,
when ΔUG cold 5′UTR futsch RNA was used as a competitor, the
band intensity corresponding to the complex formed by the GST–
TBPH protein and the labeled wild type 5′UTR futsch RNA did not
decrease (Fig. 1C).
Taken together, these experiments support the hypothesis that
the interaction between TBPH/TDP-43 and the 5′UTR futsch RNA is
speciﬁc occurs through this UG-rich sequence.
2.2. RNA-protein pull down
In order to verify the interaction between both ﬂy and human
TDP-43 orthologs with futsch mRNA 5′UTR, we then performed
RNA-protein pull down assays.
In the ﬁrst experiment, GST–TBPH or GST proteins were initially
incubated with Glutathione resin. Then, in vitro transcribed wild
type 5′UTR (futsch 5′UTR wt) or ΔUG 5′UTR (futsch 5′UTR ΔUG)
RNAs were added. After several washes followed by RNA pur-
iﬁcation, RT-qPCR was used to quantify the amount of wild type or
ΔUG 5′UTR RNA pulled down by TBPH. The enrichment-fold was
normalized to the GST protein. As shown in Fig. 2A, signiﬁcant
levels of enrichment (30x) were observed for the wild type RNA
sequence and not for ΔUG RNA sequence.Fig. 2. TBPH interacts with the futsch 5′UTR. (A) RNA pull-down of the 5′UTR futsch RNA
futsch 5′UTR pulled down by GST–TBPH. The enrichment-fold is referred to the GST prote
wild type but not for ΔUG futsch 5′UTR RNA. (B) Co-immunoprecipitation of the futs
munoprecipitated by Flag-tagged TDP-43. The enrichment-fold is referred to an unrela
enrichment were observed for the wild type but not for ΔUG futsch 5′UTR RNA. This an
mRNA. Right panel: the levels of proteins used for co-immunoprecipitation experiment
TDP43 F/L and empty pEGFP-N1 vectors. Western blot analysis was carried out using anSubsequently, this speciﬁc interaction was also tested using the
human TDP-43 ortholog (Fig. 2B, upper panel). In this experiment,
HEK293 cells were transfected with pFLAG-TDP43, pFLAG-TDP43
F/L or pEGFP-N1 vectors. Then, cell extracts expressing comparable
levels of recombinant proteins were used for RNA-protein co-im-
munoprecipitation assays (Fig. 2B, lower panel). In this case, the
enrichment-fold was referred to an unrelated protein (EGFP) or to
the mutant TDP-43 F/L (TDP-43 F/L). This mutant was used be-
cause it carries two F/L substitutions (F147L/F149L) into the ﬁrst
RNA recognition motif (RRM1) that abolish the TDP-43 RNA-
binding ability (Buratti and Baralle, 2001). Also in this case, sig-
niﬁcant levels of enrichment were observed for only the wild type
5′UTR RNA sequence and not for the ΔUG 5′UTR RNA (Fig. 2B). As
expected, no enrichment was observed for an unrelated gene
(RPL13a mRNA). On the other hand, when the preferred TDP-43/
TBPH (UG)9 RNA sequence was added to extract samples a high
level of enrichment was observed for the TDP-43 wild type protein
as opposed to the TDP-43 F/L mutant (data not shown).
Taken together, these experiments support the hypothesis that
both Drosophila and human TDP-43 orthologs interact speciﬁcally
with the UG-rich tract of the futsch 5′UTR RNA.
2.3. Futsch 5′UTR modulates translational efﬁciency
Next, we sought to understand whether the 5′UTR UG-rich tract
of futsch might directly inﬂuence translational efﬁciency. This was
performed using a cell-based luciferase assay. To set this up, we
cloned in the inducible pGL4.11 vector the Drosophila melanogaster
Hsp70Ba gene promoter (in order to get a controlled and uniform
luciferase expression) with the futsch 5′UTR sequence cloned im-
mediately upstream of the luciferase ATG-start codon. As part ofby GST–TBPH recombinant protein. This experiment shows the RT-qPCR analysis of
in used as a negative control. Signiﬁcant levels of enrichment were observed for the
ch 5′UTR RNA by TDP-43. Left panel: RT-qPCR analysis of futsch 5′UTR RNA im-
ted protein (EGFP) or to the mutant TDP-43 F/L (TDP-43 F/L). Signiﬁcant levels of
alysis conﬁrms the interaction of TDP-43 with the UG-rich tract of the 5′UTR futsch
s were evaluated in cell extracts of HEK293 transfected with pFLAG-TDP43, pFLAG-
ti-FLAG (TDP-43 wt and TDP-43 F/L), anti-GFP, and anti-Tubulin antibodies.
Fig. 3. Luciferase translational efﬁciency mediated by the futsch 5′UTR. (A) Structure of the expression vector showing the inserted sequence that included either the wild
type and ΔUG futsch 5′-UTRs sequences. (B) Luciferase activity of these vectors following transfection in Drosophila S2 cells. The relative ratio of ﬁreﬂy/renilla luciferase
activity determined from cells transfected with the plasmid carrying the wild type futsch 5′UTR was set at 1 to normalize results. The relative ratio of ﬁreﬂy/renilla luciferase
activity was signiﬁcantly lower (po0.05) for the ΔUG than the wild type futsch 5′UTR RNA. (C) Luciferase activity in HeLa cells. Left panel: Wild type and ΔUG 5′UTR
constructs were transfected into HeLa cells, along with a TBPH-wild type cDNA pFLAG-expression vector. 24 h after transfection, cells were heat shocked for 1 h at 42 °C and
the luciferase activities were measured after 6 h-restore at 37 °C. The relative ratio of ﬁreﬂy/renilla luciferase activity determined from cells transfected with the plasmid
carrying the wild type futsch 5′UTR sequence was set at 1 to normalize results. All experiments were performed in triplicate. Right panel: Western blot to determine ﬂag-
TBPH overexpression. Anti-Tubulin (Tubulin) and anti-Flag (TBPH) antibodies were used to verify the levels of TBPH overexpression in cells cotransfected with wild type and
the ΔUG futsch 5′UTR constructs (left panel). Optical densitometry (ratio TBPH/Tubulin bands) was used to compare the levels of TBPH expression. All experiments were
performed in triplicate.
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type or the ΔUG 5′UTR sequence, as negative control (Fig. 3A).
Initially, these constructs were transfected in the S2 Drosophila
cell line and preliminary setup experiments showed that the peak
of Hsp70Ba promoter activity was observed 6 h after thermal shock
(not shown). Therefore, after transfection, the induction of luci-
ferase expression was obtained by exposing the cells to thermal
shock (20 min at 37 °C) followed by a 6 h restoration period at
25 °C, before assaying luciferase activity. First of all, the results of
the initial transfection showed that luciferase activity of the futsch
5′-UTR ΔUG construct resulted signiﬁcantly lower (27%) of that
from the 5′-UTR wt (Fig. 3B). This ﬁnding suggested that the (UG)-
rich tract could inﬂuence the translational efﬁciency of the
downstream open reading frame. Subsequently, the wild type 5′
UTR and the ΔUG 5′UTR futsch constructs were transfected into
HeLa cells along with a TBPH-wild type cDNA pFLAG-expression
vector. Then, 24 h after the end of the transfection cells were heat-
shocked for 1 h at 42 °C and ﬁreﬂy/renilla luciferase activities were
measured after 6 h, as previously described. In this experiment,
the relative ratio of ﬁreﬂy/renilla luciferase activity determinedfrom cells transfected with the plasmid carrying the wild type
futsch 5′UTR was set at 1 for normalization purposes. As shown in
Fig. 3C, TBPH overexpression induced a statistically signiﬁcant
increase (22%) in the luciferase activity, and this occurred only in
presence of the wild type 5′UTR futsch sequence. In fact, TBPH
overexpression did not inﬂuence luciferase activity of the ΔUG 5′
UTR futsch construct (that remained signiﬁcantly lower than that
the wild type 5′UTR construct without TBPH overexpression,
Fig. 3C).3. Discussion
In this work, we report that both ﬂy and human TDP-43 or-
thologs interact speciﬁcally with an UG-rich sequence within the
futsch 5′ UTR mRNA and that overexpression of Drosophila TBPH
can positively modulate the translational efﬁciency only in pre-
sence of this UG-rich sequence. In fact, using an inducible pro-
moter (in order to modulate gene expression more ﬁnely com-
pared to constitutive promoters), we have found that futsch 5′UTR
M. Romano et al. / Brain Research 1647 (2016) 50–5654can positively regulate the expression the reporter gene only if the
UG-rich sequence is present.
Therefore, our data conﬁrm and extend the hypothesis of the
TBPH-dependent translational regulation of futsch gene expression
and deﬁne the sequence context required to affect the transla-
tional efﬁciency of futsch mRNA. With respect to the human
homolog of futsch, MAP1B gene, it has to be noted that the UG
sequence is not conserved. However, MAP1B has been found to be
associated with TDP-43-containing RNP complexes in mouse
models (Sephton et al., 2011), suggesting that TBPH/TDP-43 might
also play a role in the translational regulation of this transcript
(although further work will be required to clarify this issue).
Most importantly, however, this property of TBPH/TDP-43 is
probably not conﬁned to just this transcript and it is very likely
that several additional targets exist which might be affected at the
translational level. For example, at least another presynaptic pro-
tein, Cysteine string protein (csp) (Dawson-Scully et al., 2007),
might be regulated in this manner. In fact, in TBPH null ﬂies, this
synaptic marker has been found to be downregulated only at the
protein level and csp mRNA levels were not modiﬁed notwith-
standing its co-immunopreciptation by TBPH (Romano et al.,
2014a).
Also in this respect, a recent report has identiﬁed TDP-43 as a
general component of mRNP transport granules in neurons, with
its involvement in the anterograde axonal transport of target
mRNAs from the soma to distal axonal compartments, such as NMJ
(Alami et al., 2014). This ﬁnding, along with observation that some
TDP-43 mutations can alter trafﬁcking of TDP-43 cognate mRNAs
in ALS patients, has suggested that TDP-43 might support spatially
appropriate translation of target mRNAs and that the alteration of
this TDP-43 activity might contribute to neurodegeneration (Alami
et al., 2014). In summary, altogether these observations support
the hypothesis that TDP-43 might play a role in translation reg-
ulation, that is conserved through evolution and whose alteration
might contribute to the ALS pathogenesis. Consistently, futsch/
MAP1B localization seems to be altered in the spinal cord of motor
neurons of ALS patients (Coyne et al., 2014).
Therefore, further studies with patients affected by TDP-43
proteinopathy will be useful to better deﬁne the contribution of
the translational properties of this factor in ALS pathogenesis and
to test whether this activity can be modulated by TDP-43 disease-
causing mutations.4. Experimental procedure
4.1. Constructs
In order to generate an inducible Drosophila hsp70 plasmid
(pGL4–hsp70-Luc), the Hsp70Ba gene promoter from W1118
genomic DNA was ampliﬁed using the following primers:
hsp70_Kpn_s: 5′-ACTGGTACCTTATAAAGAAATTTCCAAAATAA-3′
and hsp70_HindIII_as: 5′-ATGAAGCTTTGCACTTTACTGCA-
GATTGTTTAGCTT-3′. Subsequently, the futsch 5′UTR sequence was
cloned in between the Hsp70Ba promoter and the luciferase ATG-
start codon, creating two vectors with the wild type (5′UTR wt)
and ΔUG (5′UTR ΔUG) futsch 5′UTR. To this aim, the futsch 5′UTR
sequence was ampliﬁed from W1118 genomic DNA with the fol-
lowing primer couple (5′UTR futsch _HindIII_S: 5′-CCAAGCTTAT-
TAAACAAAACCAAAAACCG-3′ and 5′UTR futsch NcoI_AS: 5′-
CTTCCATGGCACAGTTGGTGCAGTTGTAGCTGT-3′) or this couple of
primers to delete the UG-rich sequence (5′UTR futsch ΔUG_S: 5′-
GTATACCCTCTTTTTTTTCGAA-3′ and 5′UTR futsch ΔUG_AS:-
GTTCTTGCCTTTGGTTTGGGT-3′).
All PCR amplicons were initially cloned in pGEM-T easy vector
(Promega, Madison, WI, USA) and fully sequenced.4.2. Electrophoretic mobility shift assay (EMSA).
The wild type and ΔUG futsch 5′UTR RNAs were in vitro tran-
scribed using a PCR product carrying the T7 promoter (5′-TAA-
TACGACTCACTATAGGG-3′). The ampliﬁcation was obtained using
futsch -T7_2: 5′-TAATACGACTCACTATAGGGTAACAAGGGAA-
CACCCAGAGTA-3′ and futsch 5′UTR þ127: 5′-
TGTTCTTGCCTTTGGTTTG-3′. The production of recombinant GST
proteins and EMSA were performed as previously described (Ayala
et al., 2005; Buratti and Baralle, 2001; D'Ambrogio et al., 2009).
4.3. RNA-GST pull down
In vitro transcribed wild type or ΔUG futsch 5′UTR RNA (0.1ng)
was added to total W1118 ﬂy RNA (1 mg) in 500 μl of HEGN buffer
(20 mM Hepes pH 7.7, 150 mM NaCl, 0.5 mM EDTA, 10% Glycerol,
0.1% Triton X-100, 1 mM DTT). In a parallel experiment, 0.1 ng of
(UG9) in vitro transcribed RNA was used as positive control.
The RNA mix was incubated 1 h at 4 °C, and then 30 μl of
Glutathione-Superﬂow resin (Clontech, Mountain View, CA). After
4 wash cycles (each 10 min at 4 °C in rotation) with 1 ml of wash
buffer (HEGN buffer with 0.2% Deoxycholic acid, DOC, and 0.5 M
urea), RNA was extracted with Trifast reagent (Euroclone, Milan,
Italy), according to manufacturer's instruction. Reverse transcrip-
tion was performed using M-MLV Reverse Transcriptase (Gibco-
BRL, Life Technologies Inc., Frederick, MD, USA) according to
manufacturer's protocol with an oligo speciﬁc for the futsch 5′UTR
construct.
4.4. Cell cultures, transfections and luciferase assays
D. melanogaster S2 cells were maintained in Schneider's Dro-
sophila Medium containing 10% FBS and 1x Antibiotic Antimycotic
Solution (Sigma, St. Louis, MO, USA) at 25 °C. Transfections of
2105 S2 cells in 24-well dishes were carried out with 1.1 mg of
DNA (pGL4 vectors 1000 ng of Renilla vector and 100 ng of pRe-
nilla) using Effectene reagent (Qiagen, Valencia, CA, USA). At about
24 h after the end of transfections, S2 cells were heat shocked for
20 min at 37 °C and then restored for 6 h at 25 °C, before under-
going luciferase assays performed with the Dual-Luciferase Re-
porter Assay system (Promega, Madison, WI, USA).
Human Embryonic Kidney 293 (HEK293) cells were maintained
in Dulbecco's modiﬁed Eagle's medium-Glutamax-I (Gibco-BRL,
Life Technologies Inc., Frederick, MD, USA) containing 10% fetal
bovine serum (Gibco-BRL, Life Technologies Inc., Frederick, MD,
USA) and 1x Antibiotic Antimycotic Solution (Sigma, St. Louis, MO,
USA). Co-transfections of 2105 HEK-293 cells in 6-well dishes
were carried out with 500 ng of pFLAG-TBPH (Ayala et al., 2005;
Ayala et al., 2011; D'Ambrogio et al., 2009) or empty pFLAG con-
structs and pGL4-hsp70-futsch 5′UTR (300 ng)/pRenilla (20 ng)
vectors using Effectene reagent. At about 24 h after the end of
transfections, HEK-293 cells were heat shocked for 1 h at 42 °C and
then restored for 6 h at 37 °C before undergoing luciferase assays,
performed with the Dual-Luciferase Reporter Assay system.
4.5. RNA-protein co-immunoprecipitations
Cells transfected with the constructs pFLAG-TDP43 wt, pFLAG-
TDPΔFL, pEGFP-N1 were harvested 48 h after the end of trans-
fections, washed with PBS and resuspended in 500 μl of HEGN
buffer (20 mM Hepes pH 7.7, 150 mM NaCl, 0,5 mM EDTA, 10%
Glycerol, 0.1% Triton X-100, 1 mM DTT) containing 2x Cocktail
Protein Inhibitors (Roche Diagnostic GmbH, Mannheim, Germany)
and 5 μl of RNAse inhibitor (Ambion, Austin, TX, USA, 40 U/μl).
After sonication, each sample was divided in aliquots and in vitro
transcribed wild type or ΔUG 5′UTR futsch RNAs (0.1 ng) or 0.1 ng
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4 °C with 0.5 μg/ml of anti-FLAG M2 mouse monoclonal or
monoclonal Anti-Green Fluorescent Protein (Sigma, St. Louis, MO,
USA) antibody in PBS containing 0.1% Tween 20 and 3% Bovine
Serum Albumin (Sigma, St. Louis, MO, USA). Then, 30 ml of A/G Plus
agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA) were
added to each co-immunoprecipitation sample (2 h at 4 °C in ro-
tating wheel). After this incubation, ﬁve wash cycles (5 min/each
at 4 °C in rotating wheel; centrifugation at 5000 g for 10 min)
were carried with HEGN buffer containing 0.2% DOC and 0.5 M
urea. RNA extraction and reverse transcription were carried out as
described in the RNA-GST pull down section.
4.6. Quantitative real-time PCR analysis
All quantitative PCRs were performed on a CFX96 real-time PCR
detection system (Bio-Rad, Hercules, CA, USA), with primers spe-
ciﬁc for futsch 5′UTR or UG9 amplicons (Godena et al., 2011). All
ampliﬁcations were performed on a CFX96 Real-Time PCR Detec-
tion System (Bio-Rad, CA, USA). In order to calculate the enrich-
ment fold, all data were initially normalized to the respective in-
puts. The signal was measured and represented according to fold
increases compared to the control signal. The enrichment-fold is
referred to pull down experiments with GST protein. The results
derived from three independent immunoprecipitation experi-
ments and error bars were used to calculate standard deviations
on the normalized ratios.
4.7. Western blots
Cell pellets were resuspended in lysis buffer (10 mM Tris–HCl,
pH 7,4, 150 mM NaCl, 5 mM EDTA, 0.5% Triton-X100) containing 1x
Complete Protease Inhibitor Cocktail (Roche Diagnostics, Man-
nheim, Germany) and were sonicated with Bioruptor Sonication
System (Diagenode, Liege, Belgium). Proteins were separated by
10% SDS-PAGE, transferred to nitrocellulose membranes (What-
man, Clifton, NJ, USA), blocked overnight in 3% BSA, and probed
with the following primary antibodies: mouse anti-FLAG (1:2000,
SigmaAldrich, St. Louis, MO, USA) and mouse anti-Tubulin
(1:10,000, Calbiochem, San Diego, CA, USA). Membranes were
then incubated with HRP-labeled anti-mouse (Dako, Heverlee,
Belgium, 1:2000) secondary antibody. Finally, protein detection
was assessed with ECL Western Blotting Substrate (Thermo Sci-
entiﬁc, Rockford, IL, USA). Protein expression was quantiﬁed with
the NIH ImageJ software (Schneider et al., 2012) and normalized
versus Tubulin. Histograms are representative of 3 independent
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